Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Levetiracetam
Keppra
Routinely available
SMC (394/07)
09/11/2023
Indication
Adjunctive therapy in treatment of partial onset seizures with or without sedondary generalisation in children from 4 years of age with epilepsy
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
250mg, 500mg, 750mg, 1000mg tablets and oral solution 100mg/ml
Comments
-
Link to Advice
Advice Published
11/02/2008
SMC Submission Type
Resubmission
SMC Status
Accepted